Please login to the form below

Not currently logged in
Email:
Password:

European Parliament

This page shows the latest European Parliament news and features for those working in and with pharma, biotech and healthcare.

It’s Brexit day – now comes the really hard stuff

It’s Brexit day – now comes the really hard stuff

The withdrawal agreement was ratified this week, unamended from its latest iteration thanks to the government’s 80-strong majority, and passed an EU Parliament vote on Wednesday, prompting both celebrations ... Meanwhile, a European Parliament

Latest news

More from news
Approximately 3 fully matching, plus 115 partially matching documents found.

Latest Intelligence

  • A new era in European Parliament: policymakers need to hear from pharma A new era in European Parliament: policymakers need to hear from pharma

    The trend is playing out in national elections across the continent and May’s elections for the European Parliament provided a stark example of these changing voting patterns. ... If we consider the new European Parliament, several subject specialists

  • A new EU in the making, what lies ahead for pharma? A new EU in the making, what lies ahead for pharma?

    The next summit will be held this Sunday, 30 June, just two days ahead of a key meeting of the European Parliament. ... Bearing in mind the results of the European Parliament elections and the need for a greater coalition with the right, left, centrists

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    European Parliament, entering into force on 25 May 2017. ... On the other hand the European Parliament on 14 June 2012, adopted a resolution which appeared to see regulatory change as vitally important, stating that it “urgently recommends a revision

  • LEO: Patients benefit from transparency LEO: Patients benefit from transparency

    LEO Pharma announced its commitments to trial transparency back in 2013, following a workshop on clinical trial data and transparency conducted by the European Medicines Agency (EMA). ... The meetings that followed the workshop led to the European

  • Medical device regulation - a risk-based approach to compliance Medical device regulation - a risk-based approach to compliance

    After four years of negotiation, the European Parliament has published the text of its EU Medical Device Regulation (MDR), setting the stage for sweeping changes across the medical device value chain.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • It's out - so what? It's out - so what?

    With the Pharmaceutical Strategy from the European Commission, this is definitely not the case. ... Europe’s Beating Cancer Plan is the first clear initiative from this Commission and the largest political group in the European Parliament – the

  • EU Pharmaceutical Strategy Roadmap EU Pharmaceutical Strategy Roadmap

    The publication of the European Commission’s “New Industrial Strategy for Europe” in March has recently been followed by the roadmap to develop an EU Pharmaceutical Strategy. ... Orphan Medicinal Products were a major focus. The European Parliament

  • Artificial Intelligence in healthcare

    Although, a recently passed resolution from the European Parliament should prevent such sentient and weaponised robots from becoming part of our reality any time soon.[7]. ... European Parliament. Autonomous weapon systems. Plenary session at: European

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics